Nusinersen: Impact Across the Spectrum of SMA

(4:31)

Impact of Nusinersen on Respiratory and Bulbar Function

(2:52)

New Clinical Data on Adult Nusinersen treated Patients with SMA

(2:24)

Nusinersen Treatment Outcomes in Later Onset SMA

(2:35)

Real-World Experience Treating SMA With Nusinersen

(2:49)

The Development Journey of Spinraza® (nusinersen): From Advocacy to Treatment and Beyond

(24:1econd)

Nusinersen (SpinrazaTM): The First FDA Approved Treatment for SMA

(32:14)

Nusinersen for Treatment of SMA

(4:9)

Nusinersen in Adults With 5q SMA

(6:5)

Spinraza Side Effects: Understanding the Benefits and Risks of this Life-Changing Treatment

(11:55)

nusinersen

(1:16)

Nusinersen Treatment for SMA

(4:23)

Nusinersen: The First Approval for Spinal Muscular Atrophy

(9:2)

Spinraza (nusinersen) Approval

(4:35)

Nusinersen ENDEAR-SHINE and CHERISH-SHINE for SMA

(3:9)

Nusinersen Treatment for Older Patients with SMA

(3:10)

New Clinical Data on Pediatric Nusinersen treated Patients with SMA

(4:21)

Approval of Nusinersen for SMA

(4:27)

Nusinersen Phase 2 NURTURE Trial for SMA

(2:36)

Nusinersen Studies Continue To Show Efficacy And Safety

(4:46)